Similar Articles
1711 Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis
1712 Expression of p57kip2 and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma
1713 Decreased expression of type II tumor suppressor gene RARRES3 in tissues of hepatocellular carcinoma and cholangiocarcinoma
1714 Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues
1715 Fumagillin treatment of hepatocellular carcinoma in rats: An in vivo study of antiangiogenesis
1716 Tumor vaccine against recurrence of hepatocellular carcinoma
1717 Knockdown of survivin gene expression by RNAi induces apoptosis in human hepatocellular carcinoma cell line SMMC-7721
1718 Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma
1719 Do the expressions of gap junction gene connexin messenger RNA in noncancerous liver remnants of patients with hepatocellular carcinoma correlate with postoperative recurrences?
1720 Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA